Stock Movers: Metsera, Instacart, Tyson Foods (Podcast)

Metsera shares plunged after Novo Nordisk withdrew its bid, ending a bidding war with Pfizer for the experimental weight-loss drug maker, citing potential overvaluation and regulatory risks. In contrast, Instacart's stock surged following better-than-expected third-quarter results, driven by robust grocery delivery demand with orders up 14% and total revenue exceeding estimates. Meanwhile, Tyson Foods rallied despite projecting flat adjusted operating income for the next fiscal year and continued losses in its beef segment, suggesting a more favorable market interpretation of its outlook than the underlying figures might imply.

Analysis

Metsera (MTSR) shares experienced a significant premarket decline following Novo Nordisk's (NVO) withdrawal from the bidding war for the experimental weight-loss drug maker, effectively ending the contest with Pfizer (PFE). Novo's decision was influenced by concerns over potentially overpaying for an unproven asset and regulatory risks flagged by the US Federal Trade Commission regarding the proposed deal structure. This development highlights the increasing scrutiny on M&A in the pharmaceutical sector, particularly for high-growth, unproven assets.

In contrast, Instacart (CART) shares surged after reporting strong third-quarter results that surpassed analyst expectations. The online grocery company saw orders grow 14% year-over-year to 83.4 million, exceeding the 82.9 million forecast, demonstrating robust demand for its core delivery service. Total revenue reached $939 million, also beating estimates, underscoring effective execution and sustained consumer engagement.

Tyson Foods (TSN) rallied despite issuing fiscal 2026 guidance for adjusted operating income of $2.1 billion to $2.3 billion, largely flat compared to this year's $2.29 billion. The company anticipates continued challenges in its beef segment, projecting an adjusted operating loss of $400 million to $600 million next year, similar to the $426 million loss this year. The positive market reaction suggests investors may be pricing in a bottoming out or better-than-expected performance relative to prior low expectations.

Key Decisions for Investors

• Investors should reassess positions in M&A targets like Metsera, given the heightened regulatory scrutiny and valuation concerns that can abruptly halt deals.
• Consider Instacart's sustained demand and strong Q3 beat as indicators of resilient core business performance, potentially justifying further upside.
• Monitor Tyson Foods' beef segment performance closely for signs of stabilization or improvement, as the market's positive reaction to flat guidance suggests a potential re-rating based on perceived bottoming.